Browsing by Author "Can, Hatice"
Now showing items 1-3 of 3
-
The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis
Can, Günay; Ayvaz, Süleyman; Can, Hatice; Karaboğa, İhsan; Demirtaş, Selim; Aksit, Hasan; Yılmaz, Begümhan; Korkmaz, Mustafa; Kurt, Mevlüt; Karaca,Turan (Oxford Univ, 2016)Background: Ulcerative colitis is an inflammatory condition limited to the colon in the gastrointestinal system. Currently the most potent medications used for medical treatment of ulcerative colitis produce no response ... -
The efficacy of tyrosine kinase inhibitor dasatinib on colonic mucosal damage in murine model of colitis
Can, Güray; Ayvaz, Süleyrnan; Can, Hatice; Karaboğa, İhsan; Yılmaz, Bülent; Kurt, Mevlüt; Karaca, Turan; Akşit, Hasan (Elsevier Masson, 2016)Background and objective: Ulcerative colitis is an inflammatory condition of the colon in the gastrointestinal system. Currently, the most potent medications used for ulcerative colitis produce no response in 20-30% of ... -
The syk inhibitor fostamatinib decreases the severity of colonic mucosal damage in a rodent model of colitis
Can, Güray; Ayvaz, Süleyman; Can, Hatice; Demirtaş, Selim; Akşit, Hasan; Yılmaz, Bülent; Korkmaz, Uğur; Kurt, Mevlüt; Karaca, Turan (Oxford Univ Press, 2015)Background and aims: Inflammatory bowel disease is a chronic inflammatory disease of the gastrointestinal system. In some cases, current medications used for inflammatory bowel disease may not be enough for remission, ...